secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tango Therapeutics, Inc. (TNGX)
CIK:        0001819133
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0000950170-22-011475
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tango Therapeutics shareholders elect Calhoun and Huber as Class I directors, ratify PwC as auditor
--------------------------------------------------------------------------------

- Lesley Ann Calhoun elected with 74,549,730 votes for, 2,532,608 withheld, 4,658,458 broker non-votes.
- Reid Huber elected with 74,547,606 votes for, 2,534,732 withheld, 4,658,458 broker non-votes.
- PricewaterhouseCoopers ratified as independent auditor for FY2022 with 81,737,938 votes for, 400 against, 2,458 abstain.
- Annual meeting held June 8, 2022; 81,740,796 shares represented (93.19% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819133/000095017022011475/0000950170-22-011475-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819133/000095017022011475/tngx-20220608.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-011475

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer